Sign in
4

Changes in Ownership

ProPhase Labs, Inc. Filed Acc 0001493152-24-010572

Options or other derivatives

  • Director acquired 70,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
GLECKEL LOUIS MD Director 2024-03-17 Grant or award · Option (right to buy) +70,000 70,000 D
Loading xslF345X05/ownership.xml…